> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Clears Quantel Easyret Eye Laser
- URL: https://www.fdaweb.com/fda-clears-quantel-easyret-eye-laser/
- Published: 2017-07-27T12:00:00.000Z
- Updated: 2026-09-14T22:36:45.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5139244

FDA has approved a Quantel Medical PMA for the Easyret fully integrated 577nm yellow photocoagulator, indicated for use to treat certain forms of macular edema and peripheral retinal pathologies. The device is based on Quantel’s proprietary ELBA fiber laser technology, which “delivers pure 577nm yellow wavelength in a uniform top-hat laser spot profile, making it ideal for ophthalmic applications,” the company says. The device has a broad range of settings for treating diabetic retinopathy, macular edema and central serous chorioretinopathy, it adds. In addition to SingleSpot treatment mode, surgeons can select Multispot mode for a pattern of simultaneous targets or the SubLiminal mode, which enables them to customize a train of short pulses to precisely manage the thermal effect on targeted tissues.